logo

λεπτομέρειες για τα προϊόντα

Created with Pixso. Σπίτι Created with Pixso. προϊόντα Created with Pixso.
Δοκιμή μολυσματικών ασθενειών
Created with Pixso.

IRSC-502 -- RSV and SARS-CoV-2 Antigen Combo Rapid Test (Nasopharyngeal Swab)

IRSC-502 -- RSV and SARS-CoV-2 Antigen Combo Rapid Test (Nasopharyngeal Swab)

Ονομασία μάρκας: ALLTEST
Αριθμός μοντέλου: IRSC-502
Λεπτομέρειες
Τόπος καταγωγής:
ΚΙΝΑ
Πιστοποίηση:
CE
Ακρίβεια:
RSV: 96,1% SARS-CoV-2: 98,2%
Χρόνος Διαβάσεως:
15 λεπτά
Όροι αποθήκευσης:
2-30°C
ΚΑΕ:
Διαθέσιμος
Εξάρτηση δοκιμής:
10T
Σχήμα και διάταξις βιβλίου:
Κασέτα
δείγματα:
Nasopharyngeal πατσαβούρα
Περιγραφή του προϊόντος

The RSV and SARS-CoV-2 Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of RSV and SARS-CoV-2 infectious diseases in human nasopharyngeal swab specimens as an aid in the diagnostic of RSV and SARS-CoV-2 infectious diseases.

 

RSV (Respiratory Syncytial Virus) and SARS-CoV-2 (the virus that causes COVlD-19) areboth highly contagious respiratory viruses, but they affect populations differently. RSV isa leading cause of severe respiratory illness in infants and older adults, while SARS-CoV-2has caused a global pandemic affecting all age groups. Symptoms of RSV often resemblea common cold but can escalate to bronchiolitis or pneumonia, characterized by severecough, wheezing, and difficulty breathing. In contrast, SARS-CoV-2 infection (COVID-19)presents with a wider range of symptoms, including fever, cough, fatigue, and loss ottaste or smell. While many cases are mild, it can lead to severe pneumonia, acute respira-tory distress syndrome (ARDS), and systemic complications.

 

Product Advantages:
Fast Results in 15 Minutes
High Accuracy
Easy Visual Interpretation
Convenient Procedure

 

Format Cassette Specimen Nasopharyngeal Swab
Certificate CE Reading Time 15 minutes
Storage Temperature 2-30°C Sensitivity RSV: 93.2% SARS-CoV-2: 96.4%
Specificity RSV: 98.1% SARS-CoV-2: 99.0% Accuracy RSV: 96.1% SARS-CoV-2: 98.2%
Pack 10 T